Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study

Zhongying Zhang,1 Xiang Gu,2 Xianghua Fang,3 Zhe Tang,4 Shaochen Guan,3 Hongjun Liu,3 Xiaoguang Wu,3 Chunxiu Wang,3 Yan Zhao5 1Geriatric Department, Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Medical Affair Department,...

Full description

Bibliographic Details
Main Authors: Zhang Z, Gu X, Fang X, Tang Z, Guan S, Liu H, Wu X, Wang C, Zhao Y
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/homocysteine-and-the-risk-of-cardiovascular-events-and-all-cause-death-peer-reviewed-article-TCRM
_version_ 1818852492197232640
author Zhang Z
Gu X
Fang X
Tang Z
Guan S
Liu H
Wu X
Wang C
Zhao Y
author_facet Zhang Z
Gu X
Fang X
Tang Z
Guan S
Liu H
Wu X
Wang C
Zhao Y
author_sort Zhang Z
collection DOAJ
description Zhongying Zhang,1 Xiang Gu,2 Xianghua Fang,3 Zhe Tang,4 Shaochen Guan,3 Hongjun Liu,3 Xiaoguang Wu,3 Chunxiu Wang,3 Yan Zhao5 1Geriatric Department, Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Medical Affair Department, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 3Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 4Beijing Geriatric Healthcare Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Education Department, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xianghua FangEvidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing 100053, People’s Republic of ChinaTel/Fax +86-010-63153439Email fangxh_2015@126.comBackground: The association between homocysteine and cardiovascular diseases (CVD) and all-cause death was inconclusive. A community-based prospective cohort study was carried out in Beijing to evaluate this association in elderly population for more effective clinical prediction and primary prevention of CVD.Patients and Methods: Participants were randomly selected from Beijing, China. Questionnaire survey, physical examinations, and laboratory tests were carried out to collect baseline information and investigate clinical characteristics. Each participant was predetermined to be followed by 5 years. CVD events and death were collected as primary variables. A Cox regression analysis was performed to assess the risk of CVD events, CVD death, and all-cause death contributed by homocysteine as well as some other risk factors.Results: A total of 1257 participants with an average age of 69.16 years were enrolled in this study. After adjusting for confounders, the hazard ratios (HRs) and 95% confidence intervals of CVD event, CVD death, and all-cause death caused by intermediate-to-severe hyperhomocysteinemia as compared with normal homocysteine levels were 1.68 (95% CI 1.06– 2.67), 1.97 (95% CI 0.95– 4.29) and 2.02 (95% CI 1.26– 3.24), respectively. Intermediate-to-severe hyperhomocysteinemia increased the risks of CVD event (HR 2.07, 95% CI 1.01– 4.26) and all-cause death (HR 3.08, 95% CI 1.56– 6.07) among male participants. However, the positive association was not statistically significant among female participants (HR 1.59, 95% CI 0.83– 3.04 for CVD event and HR 0.90, 95% CI 0.52– 6.07 for all-cause death). Every 5μmol/L increment in homocysteine concentration was shown to be associated with a 4% (HR 1.04, 95% CI 1.01– 1.07) and 5% (HR 1.05, 95% CI 1.01– 1.07) higher risk of CVD events and all-cause death in all participants. There was no significant association between moderate hyperhomocysteinemia and the risk of the CVD events and all-cause death.Conclusion: Intermediate-to-severe hyperhomocysteinemia was significantly associated with CVD events and all-cause death in elderly population without a history of ischemia or congestive heart failure (CHF). The positive association was pronounced among males.Keywords: homocysteine, cardiovascular disease, all-cause death, prospective cohort study
first_indexed 2024-12-19T07:21:47Z
format Article
id doaj.art-a41e9650ff5e4236a522e660ec14d712
institution Directory Open Access Journal
issn 1178-203X
language English
last_indexed 2024-12-19T07:21:47Z
publishDate 2020-05-01
publisher Dove Medical Press
record_format Article
series Therapeutics and Clinical Risk Management
spelling doaj.art-a41e9650ff5e4236a522e660ec14d7122022-12-21T20:30:55ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2020-05-01Volume 1647148154013Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort StudyZhang ZGu XFang XTang ZGuan SLiu HWu XWang CZhao YZhongying Zhang,1 Xiang Gu,2 Xianghua Fang,3 Zhe Tang,4 Shaochen Guan,3 Hongjun Liu,3 Xiaoguang Wu,3 Chunxiu Wang,3 Yan Zhao5 1Geriatric Department, Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Medical Affair Department, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 3Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 4Beijing Geriatric Healthcare Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Education Department, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xianghua FangEvidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing 100053, People’s Republic of ChinaTel/Fax +86-010-63153439Email fangxh_2015@126.comBackground: The association between homocysteine and cardiovascular diseases (CVD) and all-cause death was inconclusive. A community-based prospective cohort study was carried out in Beijing to evaluate this association in elderly population for more effective clinical prediction and primary prevention of CVD.Patients and Methods: Participants were randomly selected from Beijing, China. Questionnaire survey, physical examinations, and laboratory tests were carried out to collect baseline information and investigate clinical characteristics. Each participant was predetermined to be followed by 5 years. CVD events and death were collected as primary variables. A Cox regression analysis was performed to assess the risk of CVD events, CVD death, and all-cause death contributed by homocysteine as well as some other risk factors.Results: A total of 1257 participants with an average age of 69.16 years were enrolled in this study. After adjusting for confounders, the hazard ratios (HRs) and 95% confidence intervals of CVD event, CVD death, and all-cause death caused by intermediate-to-severe hyperhomocysteinemia as compared with normal homocysteine levels were 1.68 (95% CI 1.06– 2.67), 1.97 (95% CI 0.95– 4.29) and 2.02 (95% CI 1.26– 3.24), respectively. Intermediate-to-severe hyperhomocysteinemia increased the risks of CVD event (HR 2.07, 95% CI 1.01– 4.26) and all-cause death (HR 3.08, 95% CI 1.56– 6.07) among male participants. However, the positive association was not statistically significant among female participants (HR 1.59, 95% CI 0.83– 3.04 for CVD event and HR 0.90, 95% CI 0.52– 6.07 for all-cause death). Every 5μmol/L increment in homocysteine concentration was shown to be associated with a 4% (HR 1.04, 95% CI 1.01– 1.07) and 5% (HR 1.05, 95% CI 1.01– 1.07) higher risk of CVD events and all-cause death in all participants. There was no significant association between moderate hyperhomocysteinemia and the risk of the CVD events and all-cause death.Conclusion: Intermediate-to-severe hyperhomocysteinemia was significantly associated with CVD events and all-cause death in elderly population without a history of ischemia or congestive heart failure (CHF). The positive association was pronounced among males.Keywords: homocysteine, cardiovascular disease, all-cause death, prospective cohort studyhttps://www.dovepress.com/homocysteine-and-the-risk-of-cardiovascular-events-and-all-cause-death-peer-reviewed-article-TCRMhomocysteinecardiovascular diseaseall-cause deathprospective cohort study
spellingShingle Zhang Z
Gu X
Fang X
Tang Z
Guan S
Liu H
Wu X
Wang C
Zhao Y
Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
Therapeutics and Clinical Risk Management
homocysteine
cardiovascular disease
all-cause death
prospective cohort study
title Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
title_full Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
title_fullStr Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
title_full_unstemmed Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
title_short Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
title_sort homocysteine and the risk of cardiovascular events and all cause death in elderly population a community based prospective cohort study
topic homocysteine
cardiovascular disease
all-cause death
prospective cohort study
url https://www.dovepress.com/homocysteine-and-the-risk-of-cardiovascular-events-and-all-cause-death-peer-reviewed-article-TCRM
work_keys_str_mv AT zhangz homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT gux homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT fangx homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT tangz homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT guans homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT liuh homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT wux homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT wangc homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy
AT zhaoy homocysteineandtheriskofcardiovasculareventsandallcausedeathinelderlypopulationacommunitybasedprospectivecohortstudy